0001593968-21-000271.txt : 20210201
0001593968-21-000271.hdr.sgml : 20210201
20210201162340
ACCESSION NUMBER: 0001593968-21-000271
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210201
DATE AS OF CHANGE: 20210201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pande Atul
CENTRAL INDEX KEY: 0001643071
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38958
FILM NUMBER: 21576978
MAIL ADDRESS:
STREET 1: C/O AXOVANT SCIENCES, INC.
STREET 2: 1441 BROADWAY, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karuna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771917
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270605902
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 ARCH STREET
STREET 2: SUITE 3110
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-449-2244
MAIL ADDRESS:
STREET 1: 33 ARCH STREET
STREET 2: SUITE 3110
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2021-02-01
0001771917
Karuna Therapeutics, Inc.
KRTX
0001643071
Pande Atul
C/O KARUNA THERAPEUTICS, INC.
33 ARCH ST STE 3110
BOSTON
MA
02110-1424
true
false
false
false
Common Stock
2021-02-01
4
M
false
2500
16
A
2500
D
Common Stock
2021-02-01
4
S
false
2500
100
D
0
D
Option (right to buy)
16
2021-02-01
4
M
false
2500
0
D
2020-06-27
2029-06-27
Common Stock
2500
30000
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
/s/ Troy Ignelzi, Attorney-in-Fact
2021-02-01